The Effect of Complementary and Alternative Medicine for Treatment of Gliomas
A Comprehensive Systematic Review
Keywords:
alternative, complementary, gliomaAbstract
Background: Since the majority of GBM patients are aware that there is no known cure, it makes sense that they would want to know about complementary, alternative, and CIM therapies. Methods: This systematic review focused on full-text English literature published between 2014 and 2024 using the PRISMA 2020 guidelines. The literature was compiled using PubMed, ScienceDirect, and SagePub, among other online venues. Result: Five publications were found to be directly related to our ongoing systematic examination after a rigorous three-level screening approach. Conclusion: complementary and alternative medicine methods to comfor patients with gliomas with the medication side effects that taking control of the disease. The findings of this systematic review helped to educate the providers and patients to stimulate more research according to complementary and alternative medicine for treatment of gliomas.
References
National Center for ComplementaryIntegrative Health. Complementary, alternative, or integrative health: What’s in a name? 2021;
Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;
Munoz-Casabella A, Wahner-Roedler DL, Croghan IT, Petterson TM, Fuehrer DL, Bauer BA. Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center. Glob Adv Health Med. 2022 Feb 11;11.
Krez D, Klink B, Hartmann C, von deimling A, Pietsch T. Long-term survival with glioblastoma multiforme. Brain. 2007;
Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R, Ton JC. Complementary therapy use in patients with glioma: an observational study. Neurology. 2010;75(24):2229–35.
Grech N, Dalli T, Mizzi S, Meilak L, Calleja N, Zrinzo A. Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population. Cureus. 2020 May 19;
Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, et al. Complementary and alternative medicine use in glioma patients in France. J Neurooncol. 2019;145(3):487–99.
Eisele G, Roelcke U, Conen K, Huber F, Weiss T, Hofer S, et al. Complementary and alternative medicine use by glioma patients in Switzerland. Neurooncol Pract. 2019;6(3):237–44.
Walker BC, Mittal S. Antitumor activity of curcumin in glioblastoma. Vol. 21, International Journal of Molecular Sciences. MDPI AG; 2020. p. 1–11.
Olivier C, Oliver L, Lalier L, Vallette FM. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Vol. 7, Frontiers in Molecular Biosciences. Frontiers Media S.A.; 2021.
Ramírez-Expósito MJ, Martínez-Martos JM. The Delicate Equilibrium between Oxidants and Antioxidants in Brain Glioma. Curr Neuropharmacol. 2018 Mar 7;17(4):342–51.
El-Khouly FE, Adil SM, Wiese M, Hulleman E, Hendrikse NH, Kaspers GJL, et al. Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry study. Pediatr Blood Cancer. 2021;
Pangal DJ, Baertsch H, Kellman EM, Cardinal T, Brunswick A, Rutkowski M. Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles. World Neurosurg. 2021;151:682–92.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;
Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2008;
Molassiotis A, Fernandez-Ortega P, Pud D. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yosie Yulanda Putra, Deby Tri Lestari, Ahsan Auliya, Astrid Ananda, Afdila Syarfina, Ririn Azhari, Bella Merisa L (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
